New startup ideas · Health and bio · Healthcare and bio
startup idea
Retrieva
A licensed records network with couriers for the charts no API can reach.
Retrieva is a records retrieval API for health plans, pharma safety teams and large provider groups that need complete patient charts, not the subset that sits in an EHR interface.
- Infrastructure and APIs
- Enterprise
- $100B+ market
- Creates a new category
- US first
4/5
venture judge
5
similar startups, last 2 years (19 all-time)
96%
of 3 nearest real companies still alive
yes
8 matching federal grants and programs
Direction supported by government programs and grants
Test it before you build it
$2,400 · 6 weeks · 20 prospects
For under $2,500 and 6 weeks, prove that Medicare Advantage risk adjustment VPs will pay up front for a chart chase that retrieves the records their current vendor returns empty, by hand-retrieving 25 such charts and pre-selling 2 paid pilots.
1Focus group: who and where
VP or Director of Risk Adjustment at a mid-size Medicare Advantage plan (50,000 to 300,000 members, operating in 2-4 states) who ran a chart chase last season and ate a 10-20% unretrievable rate that cost them HCC revenue at sweeps
where to find 20 · LinkedIn Sales Navigator filtered to title contains 'risk adjustment' at insurance carriers with 51-1,000 employees; the RISE Association's risk adjustment webinars and RISE National attendee network; AHIP conference speaker and attendee lists
2Sell first, build later
A 250-chart risk adjustment retrieval pilot in one state, limited to charts the incumbent vendor failed to retrieve, delivered complete with an audit trail within 45 days of signing, with a guarantee: any chart not delivered complete is not paid for.
the ask · $30 per retrieved chart, $7,500 for the 250-chart pilot, invoiced 100% at signing
a real yes · A real yes is a signed pilot agreement plus BAA with the $7,500 invoice paid and a start date on the calendar. Compliments, 'send this to procurement', unpaid data-sharing pilots, and intros to the current vendor's account manager do not count.
3Small experiments
The first one attacks the riskiest assumption; each ends with a number that says whether to run the next.
1. Fifteen risk adjustment VP calls
$200 · 14 days
Send 60 connection requests and emails from the Sales Navigator list with one line: 'What share of your chart chase came back unretrievable last season, and what did each of those charts cost you?' Book 15 30-minute calls and walk through a one-page spec of the API plus courier dispatch with a completeness guarantee. Founder runs every call and logs the unretrievable rate, current per-chart price, and current vendor by name.
keep going if · 9 of 15 confirm they paid for charts that came back empty last season and ask to see pilot pricing
2. Pre-sold pilot, invoiced up front
$300 · 21 days
Email the 9 warm VPs a one-page pilot offer: a 250-chart chase in one state of their choice, only charts their incumbent failed on, $30 per chart with a written completeness guarantee, starting in 30 days, $7,500 invoiced at signing. Use a standard two-page services agreement plus BAA on DocuSign and a Stripe invoice. No deck, no demo, just the offer and a start date.
keep going if · 2 of 8 offers come back signed with the invoice paid
3. Concierge courier chart chase
$1,400 · 21 days
Before the paid pilots start, take 25 charts one friendly plan's vendor returned empty (under a signed BAA and the plan's release authorizations) and retrieve them by hand: founder works the phones and faxes, and hires one local contractor for a day of on-site scanning at the 3-5 facilities that will not mail records. Deliver results through a spreadsheet dressed as a portal, with a per-chart audit log.
keep going if · 19 of 25 charts delivered complete within 15 business days at under $40 fully loaded cost per chart
4Collect a deposit up front
Tesla took $1,000 refundable reservations for the Model 3 and $100 for the Cybertruck before building either: the deposit is the measurement, not the revenue.
$7,500
per prospect, refundable
how · A paid design-partner pilot invoiced 100% up front via Stripe invoice, signed by the VP of Risk Adjustment under a two-page services agreement and BAA; roughly 3% of what a mid-size plan spends on a season's chart chase set up: Stripe Invoicing ↗
what it reserves · A slot in the first retrieval cohort ahead of the fall chase, a locked $30 per-chart price for year one, and dedicated courier coverage in their highest-volume state
refund · Any chart not delivered complete within the 45-day window is refunded pro rata at $30 per chart, no questions asked.
target · 2 paid pilots totaling $15,000 from 15 VP conversations within 45 days
Go: build it if
2 pilots signed and paid up front, at least 9 of 15 VPs confirming a 10%+ unretrievable rate, and the concierge run delivering 19 of 25 failed charts at under $40 cost each: build the API and the licensing entity.
Kill: stop if
Fewer than 8 of 15 VPs report meaningful unretrievable volume, or 0 paid pilots from 8 signed offers sent, or concierge cost per chart exceeds $60 with under 60% completeness: the physical last mile does not pay for itself, stop.
Would you run this test?
One tap. The yes-share feeds the Demand pillar of this idea's score; nobody sees who answered.
Budgets are out-of-pocket estimates for a team of one to three, US market. Size the deposit to the deal, and check the terms before taking money in a regulated line.
Scorecard
One score that balances how trendy the idea is, the demand for it and its potential for 100x, with competition measured relative to every other idea in the catalog. Recent startup trends first, government priorities second.
92
Idea Score, 0-100 · raw 55.9 x 1.64
Active
competition: more crowded than 52% of ideas · headwind x0.74
+3.2
government priorities, secondary (23 matching grants)
Trend
66
Is the wave forming now? 2025-26 entrants vs 2023-24, rounds since 2025, the sector's live-batch direction, the 2026 trend analyst.
- Entrants 2025-26 vs 2023-24 (similar companies)70
- Rounds announced 2025+ in the sector68
- Sector direction (live batch)100
- 2026 trend analyst25
Demand
77
Does anyone want it? YC's current RFS, companies already paid for something similar, the operator judge, founders' yes-rate in decks, readers who would run the test.
- YC asks for it (current RFS: idea / sector)30
- Someone already pays (similar companies, recent / all-time)100
- Operator judge: real pain100
100x potential
72
Can it return a fund? The venture judge (double weight), market-size and moat axes, neighbours still alive, the technologist judge.
- Venture judge75
- Market size axis100
- Moat axis80
- Neighbours still alive50
- Technologist judge50
Score = 100 x cbrt(Trend x Demand x 100x) x (1 - 0.5 x crowding) + government bonus (max 5), calibrated so the 95th-percentile idea scores 90 (order never changes). A geometric mean: a weak pillar cannot be papered over. Percentiles are among the 272 ideas in the catalog; the terms matched were licensed, records, network, couriers, charts, reach, retrieval, health.
The idea in full
- What
- Retrieva is a records retrieval API for health plans, pharma safety teams and large provider groups that need complete patient charts, not the subset that sits in an EHR interface. Where a request cannot be served electronically, the same API dispatches a credentialed regional courier or on-site scanner to the facility, and the record comes back through the same endpoint with an audit trail. The company holds the release-of-information licensing and interoperability network designation itself, so buyers contract with one entity instead of forty state-level vendors.
- Why now
- Hubble (yc S26) entered the last cohort on exactly the premise that existing record APIs cannot retrieve everything, which validates the gap without covering the physical half of it; this cluster added 126 new companies in 2024 and 130 across the last two years, almost all clinical AI that is useless without complete source records.
- Wedge: first customer and entry point
- One buyer type first: mid-size Medicare Advantage plans running risk adjustment chart chases in three states, priced per retrieved chart with a completeness guarantee, sold by the founder to the VP of risk adjustment.
- Path to 100x
- US health administrative processing and data exchange is a $100B+ annual spend, and record retrieval is the mandatory input to risk adjustment, claims audit, prior authorization and litigation, all of which are priced per chart today. Whoever holds the licensing plus the physical last mile becomes the default endpoint every clinical AI buyer integrates once, which is a new category rather than a better vendor.
- Ceiling
- Per-page retrieval pricing compresses toward zero as electronic exchange matures, leaving a low-margin toll business worth a few hundred million.
- Closest real companies, as the generator saw them
- Hubble (yc S26) is the closest, an API for hard-to-reach records; Retrieva differs by owning the regulatory designation and a field retrieval crew, so it answers requests electronic-only players return empty. Lattice Health and Opalite Health sit downstream on records rather than sourcing them.
- Main risk
- National exchange frameworks make electronic retrieval near-complete faster than expected, and the field crew becomes dead weight on a shrinking tail.
Five judges
Each judge scores every idea in the catalog with a named rubric; the venture judge decides whether a card is shown at all (4-5 is venture-grade).
Venture investor
4/5
Revenue within a year on $100B+ administrative spend, and the release-of-information licensing plus courier last mile is genuinely hard to copy.
Bootstrapper
5/5
Medicare Advantage plans already pay per retrieved chart for risk adjustment, revenue within a year, dull recurring chart chases.
Operator
5/5
Medicare Advantage risk adjustment chart chases are priced per chart today and the VP of risk adjustment owns that budget; revenue within a year.
Technologist
3/5
Credentialed couriers and state-level ROI licensing are hard to assemble but are operational, not technical, and electronic exchange is eroding the tail.
Risk
5/5
Owns the release-of-information licensing and interoperability designation, bills within a year across plans, pharma safety and provider groups, no single platform dependency.
trends
2/5
Why-now is that Hubble exists; chart chases for Medicare Advantage risk adjustment were the same business in 2023, courier and all.
Similar startups in the directory
Companies whose pitch matches most of the idea's terms (licensed, records, network, couriers, charts, reach, retrieval, health): 19 all-time, 5 from the last two years. Same matching as Idea Check.
Health Gorilla provides permitted access to longitudinal health data for digital health, providers, payers, customers, and patients.
Retrieve records other APIs can't
We use AI to personalize peptides to your biology
Trial Library is an oncology clinical trials company.
Self learning computer use agent for developers
Kaspix helps OEMs ship cheaper, upgradeable edge devices faster—using swappable manufacturable analog-AI modules that cut BOM and test time without leading-edge digital chips.
Medical Record Retrieval with Zero Human Error
Using generative AI to call insurance for healthcare clinics
Turning the web into a structured database of real world events.
All-in-one app for internal communication and HR
Local onboarding for the $200B health tourism industry
Affordable insurance for the next billion Indians
The generator's reference companies
Real companies the model named as closest when it wrote the card, with their fate. A check mark is a company the radar could verify in its directory.
Public money in this direction
US federal grants, SBIR/STTR awards and open opportunities from the radar's public-money feed, matched to the idea's terms; the sector totals give the context.
8
grants and programs matching the idea
1127
startup-relevant grants in Healthcare and bio
$590M
awarded in the sector, tracked
130
opportunities open now in the sector
- I-Corps: Translation Potential of an Artificial Intelligence (AI)-Based Platform for Early Osteoporosis Risk Predictionawardhigh relevance
National Science Foundation · I-Corps · $50K · posted 2026-08-17
- I-Corps: Translation Potential of an Autonomous Brain-on-a-Chip Platform for Functional Drug Discoveryawardhigh relevance
National Science Foundation · I-Corps · $50K · posted 2026-08-14
- TrichTok: Developing a scalable, video-based mobile intervention with peer support for adolescents and emerging adults with trichotillomaniaawardhigh relevance
NIH / NIMH · SBIR phase I · $417K · posted 2026-08-01
- InVitreON: A compact and integrated platform for long-term neuronal culture incubation, recording and closed-loop stimulationawardhigh relevance
NIH / NIMH · SBIR phase I · $457K · posted 2026-08-01
- SBIR Phase II: A Clinical Decision Making tool to improve diagnosis, management and researchawardhigh relevance
National Science Foundation · SBIR Phase II · $1M · posted 2026-07-16
NIH / NINDS · SBIR phase II · $50K · posted 2025-12-01
- Development of an accessible Cognitive Behavioral Therapy digital therapeutic for individuals with Long COVIDawardhigh relevance
NIH / NINR · SBIR phase I · $383K · posted 2025-09-16
- Development of an effective, low-cost, point-of-care early detection test for oral cancer in low resource settingsawardhigh relevance
NIH / NCI · SBIR phase II · $1M · posted 2025-09-01
Market signal
What the radar sees in Healthcare and bio: new companies by cohort year, the forming YC batch, and outcomes since the February snapshot.
Healthcare and bio · 130 → 118 → 216 → 173 → 71 new companies 2022 → 2026 · 92% aliveYC S26: 14 in this cluster, 6% of the batch (was 4% in X26) (F26 is still forming: 21 listed)Since February, of 444 YC companies here: 4 acquired, 5 shut down, 37 rewrote their pitch
Design attributes
The card is one cell of a designed set: every axis below was chosen before the text was written, and the text had to realize it.
- Buyer
- Enterprise
- Business model
- Infrastructure and APIs
- Path to 100x
- Creates a new category
- Market size
- $100B+ market
- Capital intensity
- Capital-medium (ops, field teams)
- Speed to revenue
- Revenue within a year
- Technical depth
- Integrations, no-code
- Go-to-market
- Founder-led sales
- Moat
- License or regulatory moat
- Geography
- US first
- Regulation
- Some regulation
- Vibe
- Boring business
Listed under
An idea sits in its own sector and in any sector its text clearly touches.
More ideas like this
Health and bio · Healthcare and bio
Bylaw Health
The licensed medical group behind your API call, in fifty states.
Bylaw Health holds the professional corporations, state clinician licenses, supervision agreements and payer enrollments in every US state, and exposes them as endpoints: create a clinician, attach a supervising physician, enroll a location with a payer, submit an encounter under a compliant entity.
Health and bio · Healthcare and bio
Bayworks
Licensed GMP manufacturing bays for personalized therapies, sold as bookable capacity.
Bayworks builds standardized, FDA-registered cleanroom modules inside hospital systems and partner CDMO sites, then runs a marketplace where drug sponsors book manufacturing slots by the batch instead of signing multi-year suite reservations.
Health and bio · Healthcare and bio
Assaygrid
Predicts which lab runs will fail before reagents are consumed, across every instrument vendor.
Assaygrid connects to the instrument fleet of pharma, biotech and industrial R&D organizations, learns from run telemetry, reagent lots, operator steps and outcomes, and flags runs likely to fail plus the parameter change that fixes them.
Health and bio · Healthcare and bio
Overturn
Agents that fight payer denials for health systems, then sell what wins.
Overturn deploys an agent workforce inside a health system's revenue cycle that reads each denial, pulls the governing payer medical policy, assembles the clinical record and files the appeal, working through existing EHR and clearinghouse integrations rather than new infrastructure.
Health and bio · Healthcare and bio
Labmesh
Agents that design, order and run preclinical experiments across a global lab network.
Labmesh gives a biotech or pharma scientist an agent that takes a hypothesis, decomposes it into assays, prices and routes each assay to a contract lab on its network, tracks samples, and returns structured results with the raw instrument files.
Health and bio · Healthcare and bio
ChartRail
The consented medical-records rail every AI clinic runs on.
An API that lets AI-native care companies pull a patient's complete medical record with verifiable consent, by operating as a qualified participant in the national health information exchange framework and as a registered clearinghouse.
Fictional company written 2026-08-22 from MarkosWeb data; the companies, grants and numbers around it are real and tracked. Treat the idea as a research prompt, not a plan.